DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Murthy RK, Loi S, Okines A. et al.
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
N Engl J Med 2019;
DOI: 10.1056/NEJMoa1914609.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.